Psivant Therapeutics
Finith Jernigan, Ph.D. is an experienced professional who currently holds the position of Head of Molecular Design at Psivant Therapeutics. Prior to this, Finith served as a Principal at Roivant Sciences and held various positions at different companies including PTC Therapeutics, Inc. and Silicon Therapeutics. With a background in Chemistry, Finith has made significant contributions in the field of drug discovery through computational design and virtual screening efforts.
This person is not in any offices
Psivant Therapeutics
Psivant Therapeutics is advancing a paradigm shift in biotechnology by pioneering a physics-driven approach to drug design that is tightly coupled to chemistry and biology research and development. Our QUAISAR platform is purpose-built to develop novel small molecule therapeutics to address biologically and genetically validated, but previously intractable, protein targets.